GMJ Briefs
WOAH Global Laboratory Network Expands to 182 Countries, Up 26 Members Since 2015
WOAH's laboratory network has grown to 182 countries, with streamlined procedures designed to encourage further expansion in global animal health…
Federal Grantmaking Rule Threatens American Medical Research Independence, AAMC Warns
New OMB grantmaking rule risks introducing political interference into federal medical research funding decisions, warns AAMC leadership.
Low-Cost Antifibrinolytic Drug Shows Promise in Reducing Surgical Bleeding Worldwide
Tranexamic acid reduces surgical bleeding by 11% in landmark international trial of nearly 10,000 patients.
CRISPR Gene Therapy Transforms Treatment Landscape for Pediatric Blood Disorders
CRISPR gene therapy achieves 95% transfusion independence in children with sickle cell disease and beta-thalassemia, marking a major breakthrough in…
75% of Emerging Infectious Diseases Originate in Animals: WOAH Responds With Enhanced Global Surveillance
WHO estimates show 75% of emerging infectious diseases originate from animals—a statistic driving WOAH's enhanced surveillance priorities through 2031.
Uganda Identifies First Bundibugyo Virus Case of 2026 with Full Genomic Profile
Uganda confirms first 2026 Bundibugyo virus case with complete genomic sequencing, providing crucial insights for outbreak preparedness and viral surveillance.
🚨 Uganda confirms Marburg case as Ebola outbreak continues
A new case of Marburg disease has been registered in Uganda, the World Health Organization (WHO) has confirmed.Teams are already…
New Compound UNI418 Offers Promise in Reversing Cancer Drug Resistance
UNI418 compound combined with PARP inhibitors reverses drug resistance in cancer cells by disrupting DNA repair mechanisms.